Previous 10 | Next 10 |
IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its third quarter ended...
Announces Q3 2023 Financial Results Inari to Host Conference Call Today at 1:30 P.M PT / 4:30 P.M. ET IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the li...
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Inari Medical Inc. (NARI) is expected to report $0 for Q3 2023
2023-10-31 17:35:58 ET More on Inari Medical Inari Medical: A Balanced Opportunity Amid Risks Inari Medical director sells stock worth $1.4M - filing Seeking Alpha’s Quant Rating on Inari Medical Historical earnings data for Inari Medical For f...
2023-10-26 02:06:39 ET Summary Inari Medical has shown strong revenue growth and achieved its first profitable quarter since 2021, making it an attractive investment option. The company targets a largely untapped $6 billion VTE market, offering significant room for growth with its...
2023-10-19 14:13:40 ET More on Inari Medical Inari Medical Q2 2023 Earnings Call Transcript Inari Medical: Approaching Interesting Levels Seeking Alpha’s Quant Rating on Inari Medical Historical earnings data for Inari Medical Financial informa...
2023-10-18 09:17:19 ET Summary AngioDynamics reported 6% pro forma revenue growth in Q1, but the performance of its Medical Technologies business was mixed, with a troubling contraction in thrombectomy. Major growth drivers are still a year or more away and there appear to be sign...
IRVINE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its third quarter 2023 ...
2023-08-03 14:26:08 ET Shares of Inari Medical (NASDAQ: NARI) were up by more than 21% as of 1:45 p.m. on Thursday after the company reported second-quarter results after the markets closed Wednesday. The healthcare stock is up more than 5% so far this year. Inari is a medic...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
SAN FRANCISCO, June 27, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...